Home
AMGN
AMGN News

Latest Amgen Inc. (AMGN) News on April 19, 2025

Here's Why Amgen (AMGN) is a Strong Value Stock

Zacks

a day ago

Here's Why Amgen (AMGN) is a Strong Value Stock

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Zacks

2 days ago

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025

Insider Monkey

2 days ago

Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Motley Fool

2 days ago

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents

BioPharma Dive

3 days ago

Leqembi finally secures EU clearance; Sandoz sues Amgen over Enbrel patents

MT Newswires

4 days ago

Goldman Sachs Adjusts Price Target on Amgen to $400 From $408, Maintains Buy Rating

MT Newswires

5 days ago

Sector Update: Health Care Stocks Rise Monday Afternoon

MT Newswires

5 days ago

Update: Amgen Facing US Antitrust Lawsuit Filed by Sandoz

MT Newswires

5 days ago

UBS Adjusts Amgen Price Target to $319 From $315, Maintains Neutral Rating

MT Newswires

5 days ago

Goldman Sachs Adjusts Price Target on Amgen to $400 From $408

Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit

Pharmaceutical Technology

5 days ago

Sandoz challenges Amgen’s Enbrel patents in US antitrust lawsuit

MT Newswires

5 days ago

Amgen Facing US Antitrust Lawsuit Filed by Sandoz

Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC

Clinical Trials Arena

5 days ago

Amgen’s Phase III trial of Imdelltra meets primary endpoint for SCLC

Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug

Reuters

5 days ago

Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug

Amgen (AMGN) Gains But Lags Market: What You Should Know

Zacks

8 days ago

Amgen (AMGN) Gains But Lags Market: What You Should Know

MT Newswires

8 days ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires

8 days ago

Sector Update: Health Care Stocks Gain in Afternoon Trading

Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA

Simply Wall St.

8 days ago

Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA

MT Newswires

8 days ago

Citigroup Adjusts Price Target on Amgen to $290 From $295, Keeps Neutral Rating

MT Newswires

8 days ago

Amgen Says Phase 3 Trial of Lung Cancer Drug Imdelltra Met Primary Endpoint at Interim

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

PR Newswire

8 days ago

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

Amgen says Imdelltra extended survival; Parker Institute adds new leaders

BioPharma Dive

8 days ago

Amgen says Imdelltra extended survival; Parker Institute adds new leaders

Pharma’s manufacturing moment: Where companies are making the biggest moves

Pharma Voice

8 days ago

Pharma’s manufacturing moment: Where companies are making the biggest moves

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Zacks

9 days ago

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the Next Winner.

Barrons.com

9 days ago

Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the Next Winner.

MT Newswires

10 days ago

Morgan Stanley Adjusts Price Target on Amgen to $330 From $328, Keeps Equalweight Rating

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks

11 days ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.

Barrons.com

12 days ago

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.

3 Dividend Stocks to Buy and Hold for the Next Decade

Motley Fool

13 days ago

3 Dividend Stocks to Buy and Hold for the Next Decade

2 Dividend Stocks to Buy Hand Over Fist in April

Motley Fool

14 days ago

2 Dividend Stocks to Buy Hand Over Fist in April

Amgen (NasdaqGS:AMGN) Gains FDA Approval For UPLIZNA In Treating IgG4-Related Disease

Simply Wall St.

15 days ago

Amgen (NasdaqGS:AMGN) Gains FDA Approval For UPLIZNA In Treating IgG4-Related Disease

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

Zacks

15 days ago

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

MT Newswires

15 days ago

Sector Update: Health Care Stocks Decline Pre-Bell Friday

MT Newswires

15 days ago

Amgen Says Uplizna Wins US FDA Approval for IgG4-related Disease

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Zacks

16 days ago

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

Motley Fool

16 days ago

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday

UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

PR Newswire

16 days ago

UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE

US FDA approves Amgen's Uplizna as first treatment for rare immune disorder

Reuters

16 days ago

US FDA approves Amgen's Uplizna as first treatment for rare immune disorder

MT Newswires

16 days ago

RBC Lifts Price Target on Amgen to $324 From $320, Keeps Outperform Rating

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory

16 days ago

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now

Motley Fool

16 days ago

Got $5,000? These 3 Nasdaq Stocks Are Dirt Cheap Buys Right Now

GILD or AMGN: Which Is the Better Value Stock Right Now?

Zacks

18 days ago

GILD or AMGN: Which Is the Better Value Stock Right Now?

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

Investor's Business Daily

18 days ago

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

These biotech names aren't facing 'huge concern' from tariffs

Yahoo Finance Video

18 days ago

These biotech names aren't facing 'huge concern' from tariffs

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

19 days ago

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

Zacks

19 days ago

RDY & Bio-Thera Ink Deal for JNJ's Stelara/Simponi Biosimilar

2 Surefire Dividend Stocks That Could Pay You for Life

Motley Fool

22 days ago

2 Surefire Dividend Stocks That Could Pay You for Life

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

StockStory

22 days ago

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Zacks

22 days ago

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Motley Fool

22 days ago

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

Barrons.com

23 days ago

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks

23 days ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Pharma Voice

23 days ago

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

a month ago

Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note

Is Amgen Inc. (AMGN) The Best Healthcare Dividend Stock to Invest in?

Insider Monkey

a month ago

Is Amgen Inc. (AMGN) The Best Healthcare Dividend Stock to Invest in?

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Zacks

a month ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

3 of Goldman Sachs' best investing tips for currently volatile markets

Yahoo Finance

a month ago

3 of Goldman Sachs' best investing tips for currently volatile markets

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Zacks

a month ago

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Why the Market Dipped But Amgen (AMGN) Gained Today

Zacks

a month ago

Why the Market Dipped But Amgen (AMGN) Gained Today

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Zacks

a month ago

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Prediction: These 2 Stocks Will Outperform the Market Through 2030

Motley Fool

a month ago

Prediction: These 2 Stocks Will Outperform the Market Through 2030

Amgen Inc. (AMGN): Among the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey

a month ago

Amgen Inc. (AMGN): Among the Best Biotech Stocks to Buy According to Billionaires

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Zacks

a month ago

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Zacks

a month ago

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

MT Newswires

a month ago

Regeneron Shares Fall After US Appeals Court Denies Request for Stay on Eylea Biosimilars

Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer

TipRanks

a month ago

Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer

Amgen’s gMG therapy cuts disease symptoms at one-year mark

Clinical Trials Arena

a month ago

Amgen’s gMG therapy cuts disease symptoms at one-year mark

Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis

Simply Wall St.

a month ago

Amgen (NasdaqGS:AMGN) Announces Promising MINT Trial Data For UPLIZNA In Generalized Myasthenia Gravis

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds?

Insider Monkey

a month ago

Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy According to Hedge Funds?

Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year

Benzinga

a month ago

Amgen's Uplizna Shows Improved Symptoms In Patients With Muscle Weakness Disorder Over One Year

Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Exelixis (EXEL) Up 13.4% Since Last Earnings Report: Can It Continue?

MT Newswires

a month ago

Amgen Says Phase 3 Data Support Uplizna's Efficacy in Generalized Myasthenia Gravis

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS

PR Newswire

a month ago

UPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS

Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy

Insider Monkey

a month ago

Amgen Inc. (AMGN): Among Dobermans of the Dow to Buy

HALO vs. AMGN: Which Stock Is the Better Value Option?

Zacks

a month ago

HALO vs. AMGN: Which Stock Is the Better Value Option?

Stock market sell-off: Why these stocks are in the green amid the pain

Yahoo Finance

a month ago

Stock market sell-off: Why these stocks are in the green amid the pain

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Zacks

a month ago

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies

Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints

Clinical Trials Arena

a month ago

Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints

Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus

Zacks

a month ago

Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus

3 Magnificent Growth Stocks to Buy in March

Motley Fool

a month ago

3 Magnificent Growth Stocks to Buy in March

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

PR Newswire

a month ago

AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

Zacks

a month ago

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value

GuruFocus.com

a month ago

The Art of Valuation: Discovering Amgen Inc's Intrinsic Value

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Motley Fool

a month ago

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Quartz

a month ago

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?

Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy

BioPharma Dive

a month ago

Amgen readies pivotal MariTide trials; Novo offers discounted Wegovy

2 Reasons to Watch AMGN and 1 to Stay Cautious

StockStory

a month ago

2 Reasons to Watch AMGN and 1 to Stay Cautious

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now

Insider Monkey

a month ago

Amgen Inc. (AMGN): Among the Best Undervalued Stocks to Invest In Now

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

Barrons.com

a month ago

Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break Out

MT Newswires

a month ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Amgen just got one step closer to bringing its Ozempic competitor to market

Quartz

a month ago

Amgen just got one step closer to bringing its Ozempic competitor to market

Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

Simply Wall St.

a month ago

Amgen (NasdaqGS:AMGN) Declares US$2 Dividend Per Share For Q2 2025

MT Newswires

a month ago

Amgen Launches Two Phase 3 Trials for Obesity Drug MariTide

With patent losses on the horizon, Amgen refocuses its business strategy

Pharma Voice

a month ago

With patent losses on the horizon, Amgen refocuses its business strategy

AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

PR Newswire

2 months ago

AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Zacks

2 months ago

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Share on Social Networks: